Omicron-specific Sinopharm, Sinovac Covid vaccine candidates cleared for clinical trial ...Middle East

BEIJING: Covid-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday.Scientists worldwide are racing to study upgraded injections against Omicron, as data indicated that antibodies elicited by vaccines based on older strains show weaker activity to neutralise the highly transmissible variant.The two candidates from units of Sinopharm subsidiary China National Biotec Group (CNBG) and one from Sinovac contain inactivated or “killed” coronavirus and are similar to vaccines that the companies are supplying in China and overseas, the companies said in statements.The

Hence then, the article about omicron specific sinopharm sinovac covid vaccine candidates cleared for clinical trial was published today ( Saturday 16/04/2022 - 02:42 PM ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Omicron-specific Sinopharm, Sinovac Covid vaccine candidates cleared for clinical trial )

Also on site :

• Crowds attend Honor Flight Mission 94 at Rochester’s airport on Sunday
• Johnny Knoxville Takes Credit For “Monstrous Explosion” In Simi Valley During ‘Jackass: Best and Last’ Wrap
• US forces attack and seize Iranian ship Touska near Strait of Hormuz